The Asia-Pacific Knee Cartilage Repair Market is expected to grow with the CAGR of 11.1% in the forecast period of 2023 to 2030. The years considered for study are as mentioned below:
Access Full Report at @ https://www.databridgemarketresearch.com/ru/reports/asia-pacific-knee-cartilage-repair-market
Asia-Pacific knee cartilage repair market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Asia-Pacific knee cartilage repair market are introducing strong range of products provider along with launching new services and adopting strategic initiative such as acquisition, agreement, business expansion, award and recognition into the market. This helped companies to maximize the sales with enhanced service portfolio.
- In November 2021, Smith & Nephew announced the launch of CORI handheld robotics, an advanced system for both total and partial knee arthroplasties. The system is fully mobile solution incorporating a 3-D intraoperative imaging system with advanced robotic sculpting tool. This has helped the company to increase its sales as the demand of products in the market is high.
Sanofi is the dominating player in the Asia-Pacific knee cartilage market. Some other key players existing in the market include Stryker, MEDIPOST, Arthrex, Inc DePuy Synthes, Conmed, Medacta International, ANIKA THERAPEUTICS, Japan Medical Dynamic Marketing Inc , BioGend Therapeutics Co.,Ltd., B. Braun Melsungen AG, BIOTISSUE SA, CELLGENIX, Waldemar Link GmbH & Co. KG, CARTIHEAL ,INC, Regentis Biomaterials Ltd., AUXEIN MEDICAL among others.
SANOFI
Sanofi is headquartered in Paris, France was founded in 2004. It has public ownership. The company focuses on pursuing new vaccines and medicines with the potential to make life better for patients, families, and communities. It has following business segments and product categories which are prescription products, vaccines, biologics, and consumer health, among which consumer health is the market-focused segment and category.
- In January 2020, Sanofi completed the acquisition of Synthorx, Inc. Synthorx, Inc. is now a fully-owned subsidiary of Sanofi which will further help in the growth of the company's revenue.
The company has a presence in North America, Europe, Asia-Pacific, South America, the Middle East and Africa. The company has various subsidiaries that are Chattem (USA), Amunix (USA), Sanofi Medley Farmacêutica Ltda. (Sanofi Medley) (Brazil), Genzyme (USA), Sanofi Pasteur (France) among others.
Zimmer Biomet
Zimmer Biomet is headquartered in Indiana, U.S. was founded in 1927. It has public ownership. The company is engaged in providing medical products in different categories including knee, hip and shoulder among others. The company has following business segments knees, hips, S.E.T., spine & dental & others, among which knees is the market-focused segment. The company offers product categories which are knee, hip, shoulder, sports medicine, CMF, restorative therapies, thoracic biologics cement, diagnostics, elbow, foot & ankle limb salvage patient-matched, implants pharmaceuticals, surgical trauma, and knee is the market-focused category.
- In August 2021, Zimmer Biomet along with Canary Medical had announced that Food and Drug Administration (FDA), De Novo classification grant to world's first and only smart knee implant, Persona IQ knee implant. This approval would enhance the approval in other regions also and helps the company to expand its business.
The company has a presence in North America, Europe, Asia-Pacific, South America, the Middle East and Africa. The company has various subsidiaries that are Accelero Health Partners, LLC (U.S.), Biomet 3i, LLC (U.S.), Zimmer Biomet Robotics (France), Zimmer GmbH (GmbH), ReLign Corporation (U.S.) among others.
Smith & Nephew
Smith & Nephew is headquartered in London, U.K. founded in 1856. It has public ownership. The company focuses on designing and making technology by offering products in orthopedics, advanced wound management, sports, and medicine among more. The company has the following business segments such as orthopedics, sports medicine & ENT, and advanced wound management among which orthopedics is the market-focused segment. The company offers various product categories such as Advanced Wound Management, Orthopaedic Reconstruction, Trauma and Extremities, Ear, Nose and Throat, and Sports Medicine, out of which Orthopaedic Reconstruction is the market-focused category.
- In March 2022, Smith & Nephew exhibited its latest innovation for orthopedics reconstruction and robotics during the American Academy of Orthopedic Surgeons. This has helped the company to furnish correct knowledge about its products in the market.
The company has a presence in North America, Europe, Asia-Pacific, South America, the Middle East and Africa. The company has various subsidiaries that are Blue Sky Medical Group Inc (U.S.), Exogen, Inc (U.S.), Endocare GmbH (Germany), Plus Orthopedics France SAS (France) and Smith & Nephew (Europe) B.V (Netherlands) among more.
